Abiopharma

🔍 Liu Brian Guan-Chyun (Executive)

Company: CG Oncology, Inc. (CGON)

Report Date: 2026-06-25

Detailed Transactions and Holdings:

• Acquired 371,085 shares of Common Stock at $66.87 per share (Direct)
  Date: 2026-06-25 | Code: P | equity_swap_involved: 0 | shares_owned_after: 1,886,236.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: The Reporting Person, as the managing member of Seven Fleet Advisors, LLC, the investment manager of Seven Fleet Partners, LP, may be deemed to beneficially own the shares of Common Stock held by Seven Fleet Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his proportionate pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.